International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: 10.5281/zenodo.13777674
Original Research Article
Diagnostic Value of Ultra-Sonographic Guided Fine Needle Aspiration Cytology (FNAC) in Intra-Abdominal Solid Mass in Children
Published
Sept. 18, 2024
Abstract

Background: Ultrasound-guided fine needle aspiration cytology (FNAC) is an essential diagnostic tool for detecting intra-abdominal masses, offering a cost-effective, safe, and accurate method for diagnosing benign and malignant lesions. Objective: This study aimed to establish ultrasound-guided FNAC as an accurate diagnostic method for intraabdominal solid masses and correlate FNAC findings with histological results. Methods: A prospective comparative study was conducted from November 2022 to January 2024 at Sher-e-Bangla Medical College Hospital (SBMCH), Barisal, involving 45 pediatric patients (24 males, 21 females) aged 3 months to 14 years. All patients underwent both FNAC and open biopsy. Data were analysed using SPSS v. 26 software to determine the accuracy of FNAC compared to histopathological findings. Results: Out of 45 cases, 10 (22.2%) were cytologically diagnosed as benign, including 4 (8.9%) non-neoplastic and 6 (13.3%) benign neoplastic. Thirty-three (73.3%) were diagnosed as malignant. Upon histological examination, 9 cases (20%) were confirmed benign, and 36 (80%) were malignant. One case showed a false negative (malignant histology, benign cytology). There were no false positives, with a sensitivity of 97.06% and a specificity of 100%. Conclusion: Ultrasound-guided FNAC is a highly accurate, non-invasive, and cost-effective diagnostic tool for intra-abdominal solid masses in pediatric patients, significantly reducing the need for surgical interventions.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
2110 Views
39 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved